Polyplus Raises $1.8M Through Convertible Bond Issuance

The company said the money will primarily be used to support its RNAplus program, which is focused on developing RNAi oligos that do not require delivery reagents.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories